HEALIOS K.K., A Partner Of Athersys Inc (NASDAQ:ATHX), Enrolls Patients In...

0
HEALIOS K.K., an associate of Athersys Inc (NASDAQ:ATHX), completed the enrollment patients in the ONE-BRIDGE trial. In this clinical trial, the company will evaluate the...

Borealis Foods Inc. (BRLS) Soars 77%: Analyzing the Recent Surge and...

0
Borealis Foods Inc. (NASDAQ: BRLS) has captured significant market attention with a notable surge, closing the session at $7.11, up 77.75%. However,...

Biodexa Pharmaceuticals Plc (BDRX): Positive Phase 2 Results Propel Stock Upward

0
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) has recently captured the spotlight with its stock experiencing significant movements. The day’s trading saw the stock...

Popular News

MAKE IT MODERN

LATEST REVIEWS

Provention Bio Inc (NASDAQ:PRVB) Unveils Phase 2b PROACTIVE Study Of PRV-015

0
Provention Bio Inc (NASDAQ:PRVB) focuses on ways to help patients struggling with a condition known as the 'Non-Responsive Celiac Disease' (NRCD). This group of...

MAKE IT MODERN

PERFORMANCE TRAINING

Novavax Inc. (NASDAQ: NVAX) Receive Singapore Health Sciences Authority’s Approval for Nuvaxovid COVID-19 Vaccine

0
Novavax Inc. (NASDAQ: NVAX) has announced that Singapore Health Sciences Authority has issued preliminary clearance for the Nuvaxovid COVID-19 vaccine for active immunization against...

AC Immune SA (NASDAQ:ACIU) Reports Encouraging Results On the Study Of Its AD Vaccine

0
AC Immune SA (NASDAQ:ACIU) has released encouraging interim results from the on-going Phase 1b/2a clinical trial studying its first-in-class anti-phospho-Tau vaccine candidate ACY-35.030 in...

Aldeyra Therapeutics Inc (NASDAQ:ALDX) Enters A Pact With FDA To Use RASP To Treat...

0
Aldeyra Therapeutics Inc (NASDAQ:ALDX) advances several clinical-stage programs that focus on developing ADX-629 and reproxalap. The company held discussions with the FDA in June...

Imara Inc. (NASDAQ: IMRA) Receives FDA approval for Investigational New Drug Application for Tovinontrine...

0
Imara Inc. (NASDAQ: IMRA) has announced that the FDA has approved its investigational new drug application for tovinontrine (IMR-687) to start clinical development in...

One Stock Positioned to Win as EV Battery Recycling Becomes the Next Big Thing...

0
The electric vehicle narrative is about using new technology to strike at the heart of one of the most profound drivers of...

MAKE IT MODERN

POPULAR